Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-July through September 2012, 67368-67379 [2012-27422]
Download as PDF
67368
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
the individual named within the FOR
FURTHER INFORMATION CONTACT section of
this notice.
Dated: September 24, 2012.
Don Wright,
Director, Office of Disease Prevention and
Health Promotion.
and interpretive regulations, and other
Federal Register notices that were
published from July through September
2012, relating to the Medicare and
Medicaid programs and other programs
administered by CMS.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[CMS–9075–N]
Centers for Medicare & Medicaid
Services
It is
possible that an interested party may
need specific information and not be
able to determine from the listed
information whether the issuance or
regulation would fulfill that need.
Consequently, we are providing contact
persons to answer general questions
concerning each of the addenda
published in this notice.
FOR FURTHER INFORMATION CONTACT:
Medicare and Medicaid Programs;
Quarterly Listing of Program
Issuances—July through September
2012
[FR Doc. 2012–27425 Filed 11–8–12; 8:45 am]
BILLING CODE 4150–32–P
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This quarterly notice lists
CMS manual instructions, substantive
SUMMARY:
Addenda
Contact
I CMS Manual Instructions ......................................................................................................
II Regulation Documents Published in the Federal Register .................................................
III CMS Rulings ........................................................................................................................
IV Medicare National Coverage Determinations .....................................................................
V FDA-Approved Category B IDEs .........................................................................................
VI Collections of Information ....................................................................................................
VII Medicare-Approved Carotid Stent Facilities .......................................................................
VIII American College of Cardiology-National Cardiovascular Data Registry Sites ...............
IX Medicare’s Active Coverage-Related Guidance Documents ..............................................
X One-Time Notices Regarding National Coverage Provisions ..............................................
XI National Oncologic Positron Emission Tomography Registry Sites ...................................
XII Medicare-Approved Ventricular Assist Device (Destination Therapy) Facilities ................
XIII Medicare-Approved Lung Volume Reduction Surgery Facilities ......................................
XIV Medicare-Approved Bariatric Surgery Facilities ...............................................................
XV Fluorodeoxyglucose Positron Emission Tomography for Dementia Trials .......................
All Other Information ..................................................................................................................
Ismael Torres ..........................
Terri Plumb .............................
Tiffany Lafferty ........................
Wanda Belle ...........................
John Manlove .........................
Mitch Bryman ..........................
Sarah J. McClain ....................
JoAnna Baldwin, MS ..............
Lori Ashby ...............................
Lori Ashby ...............................
Stuart Caplan, RN, MAS ........
JoAnna Baldwin, MS ..............
JoAnna Baldwin, MS ..............
Kate Tillman, RN, MAS ..........
Stuart Caplan, RN, MAS ........
Annette Brewer .......................
tkelley on DSK3SPTVN1PROD with NOTICES
I. Background
Among other things, the Centers for
Medicare & Medicaid Services (CMS) is
responsible for administering the
Medicare and Medicaid programs and
coordination and oversight of private
health insurance. Administration and
oversight of these programs involves the
following: (1) Furnishing information to
Medicare and Medicaid beneficiaries,
health care providers, and the public;
and (2) maintaining effective
communications with CMS regional
offices, State governments, State
Medicaid agencies, State survey
agencies, various providers of health
care, all Medicare contractors that
process claims and pay bills, National
Association of Insurance Commissioners
(NAIC), health insurers, and other
stakeholders. To implement the various
statutes on which the programs are
based, we issue regulations under the
authority granted to the Secretary of the
Department of Health and Human
Services under sections 1102, 1871,
1902, and related provisions of the
Social Security Act (the Act) and Public
Health Service Act. We also issue
various manuals, memoranda, and
VerDate Mar<15>2010
17:34 Nov 08, 2012
Jkt 229001
statements necessary to administer and
oversee the programs efficiently.
Section 1871(c) of the Act requires
that we publish a list of all Medicare
manual instructions, interpretive rules,
statements of policy, and guidelines of
general applicability not issued as
regulations at least every 3 months in
the Federal Register.
II. Revised Format for the Quarterly
Issuance Notices
While we are publishing the quarterly
notice required by section 1871(c) of the
Act, we will no longer republish
duplicative information that is available
to the public elsewhere. We believe this
approach is in alignment with CMS’
commitment to the general principles of
the President’s Executive Order 13563
released January 2011entitled
‘‘Improving Regulation and Regulatory
Review,’’ which promotes modifying
and streamlining an agency’s regulatory
program to be more effective in
achieving regulatory objectives. Section
6 of Executive Order 13563 requires
agencies to identify regulations that may
be ‘‘outmoded, ineffective, insufficient,
or excessively burdensome, and to
modify, streamline, expand or repeal
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Phone No.
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
(410)
786–1864
786–4481
786–7548
786–7491
786–6877
786–5258
786–2294
786–7205
786–6322
786–6322
786–8564
786–7205
786–7205
786–9252
786–8564
786–6580
them in accordance with what has been
learned.’’ This approach is also in
alignment with the President’s Open
Government and Transparency Initiative
that establishes a system of
transparency, public participation, and
collaboration.
Therefore, this quarterly notice
provides only the specific updates that
have occurred in the 3-month period
along with a hyperlink to the full listing
that is available on the CMS Web site or
the appropriate data registries that are
used as our resources. This information
is the most current up-to-date
information and will be available earlier
than we publish our quarterly notice.
We believe the Web site list provides
more timely access for beneficiaries,
providers, and suppliers. We also
believe the Web site offers a more
convenient tool for the public to find
the full list of qualified providers for
these specific services and offers more
flexibility and ‘‘real time’’ accessibility.
In addition, many of the Web sites have
listservs; that is, the public can
subscribe and receive immediate
notification of any updates to the Web
site. These listservs avoid the need to
check the Web site, as notification of
E:\FR\FM\09NON1.SGM
09NON1
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
updates is automatic and sent to the
subscriber as they occur. If assessing a
Web site proves to be difficult, the
contact person listed can provide
information.
III. How To Use the Notice
tkelley on DSK3SPTVN1PROD with NOTICES
This notice is organized into 15
addenda so that a reader may access the
subjects published during the quarter
VerDate Mar<15>2010
17:34 Nov 08, 2012
Jkt 229001
covered by the notice to determine
whether any are of particular interest.
We expect this notice to be used in
concert with previously published
notices. Those unfamiliar with a
description of our Medicare manuals
should view the manuals at https://
www.cms.gov/manuals.
Authority: (Catalog of Federal Domestic
Assistance Program No. 93.773, Medicare—
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
67369
Hospital Insurance, Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program, and Program No. 93.714,
Medical Assistance Program)
Dated: November 5, 2012.
Kathleen Cantwell,
Director, Office of Strategic Operations and
Regulatory Affairs.
BILLING CODE 4120–01–P
E:\FR\FM\09NON1.SGM
09NON1
tkelley on DSK3SPTVN1PROD with NOTICES
67370
VerDate Mar<15>2010
Jkt 229001
PO 00000
Frm 00042
Fmt 4703
Addendum I: Medicare and Medicaid Manual Instructions
(July through September 2012)
The CMS Manual System is used by CMS program components,
partners, providers, contractors, Medicare Advantage organizations, and
State Survey Agencies to administer CMS programs. It offers day-to-day
operating instructions, policies, and procedures based on statutes and
regulations, guidelines, models, and directives. In 2003, we transformed the
CMS Program Manuals into a web user-friendly presentation and renamed
it the CMS Online Manual System.
Sfmt 4725
E:\FR\FM\09NON1.SGM
09NON1
How to Obtain Manuals
The Internet-only Manuals (IOMs) are a replica of the Agency's
official record copy. Paper-based manuals are CMS manuals that were
officially released in hardcopy. The majority of these manuals were
transferred into the Internet-only manual (lOM) or retired. Pub 15-1, Pub
15-2 and Pub 45 are exceptions to this rule and are still active paper-based
manuals. The remaining paper-based manuals are for reference purposes
only. If you notice policy contained in the paper-based manuals that was
not transferred to the 10M, send a message via the CMS Feedback tool.
Those wishing to subscribe to old versions of CMS manuals should
contact the National Technical Information Service, Department of
Commerce, 5301 Shawnee Road, Alexandria, VA 22312 Telephone (703605-6050). You can download copies ofthe listed material free of charge
at: https://cms.gov/manuals.
Transmittal
Nnmber
79
I
MannallSnbject/Pnblication Nnmber
January 2013 Quarterly Updates to the CMS Standard File for Reason Codes
for the Fiscal Intermediary Shared System (PISS)
00
144
145
146
How to Review Transmittals or Program Memoranda
Those wishing to review transmittals and program memoranda can
access this information at a local Federal Depository Library (FDL). Under
the FDL program, government publications are sent to approximately 1,400
EN09NO12.009
2494
2495
I None
Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Low Back
Pain (CLBP)
National Coverage Determination (NCD) for Transcatheter Aortic Valve
Replacement (TAVR)
Liver Transplantation for Patients with Malignancies Transcatheter Aortic
Valve Replacement (TAVR) Adult Liver Transplantation
Pharmacy Billing for Drugs Provided "Incident To" a Physician
Service This CR rescinds and fully replaces CR 7109.
Validation of Payment Group Codes for Prospective Payment Systems (PPS)
I
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
designated libraries throughout the United States. Some FDLs may have
arrangements to transfer material to a local library not designated as an
FDL. Contact any library to locate the nearest FDL. This information is
available at https://www.gpo.gov/libraries/
In addition, individuals may contact regional depository libraries
that receive and retain at least one copy of most federal government
publications, either in printed or microfilm form, for use by the general
public. These libraries provide reference services and interlibrary loans;
however, they are not sales outlets. Individuals may obtain information
about the location of the nearest regional depository library from any
library. CMS publication and transmittal numbers are shown in the listing
entitled Medicare and Medicaid Manual Instructions. To help FDLs locate
the materials, use the CMS publication and transmittal numbers. For
example, to find the Medicare National Coverage Determination publication
titled Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic
Low Back Pain (CLBP) use CMS-Pub. 100-03, Transmittal No. 144.
Addendum I lists a unique CMS transmittal number for each
instruction in our manuals or program memoranda and its subject number.
A transmittal may consist of a single or multiple instruction(s). Often, it is
necessary to use information in a transmittal in conjunction with
information currently in the manual. For the purposes of this quarterly
notice, we list only the specific updates to the list of manual instructions
that have occurred in the 3-month period. This information is available on
our website at www.cms.govlManuals.
Publication Dates for the Previous Four Quarterly Notices
We publish this notice at the end of each quarter reflecting
information released by CMS during the previous quarter. The publication
dates of the previous four Quarterly Listing of Program Issuances notices
are: December 16,2011 (76 FR 78267), February 21,2012 (77 FR 9931),
May 18,2012 (77 FR 29648) and August 17,2012 (77 FR 49799). For the
purposes of this quarterly notice, we are providing only the specific updates
that have occurred in the 3-month period along with a hyperlink to the
website to access this information and a contact person for questions or
additional information.
tkelley on DSK3SPTVN1PROD with NOTICES
VerDate Mar<15>2010
2498
2499
Jkt 229001
2500
PO 00000
2501
Frm 00043
2502
2503
Fmt 4703
2504
Sfmt 4725
2506
2507
2505
E:\FR\FM\09NON1.SGM
2508
2509
2510
2511
2512
09NON1
2513
2514
2515
2516
2517
2518
2519
2520
2521
2522
2523
2524
2525
2526
2527
2528
2529
2530
2531
2532
2533
2534
2535
Code or Where an ICD-lO VOO-Y99 Code is Reported as the First Diagnosis
on the Claim
Conditional Data Element Requirements for AlB MACs and DMEMACs
Consolidated Claims Crossover Process
Claims Crossover Disposition and Coordination of Benefits Agreement ByPass Indicators
New Non- Physician Specialty Code for Centralized Flu Nonphysician
Practitioner, Supplier, and Provider Specialty Codes
Medicare Claims Processing Pub. 100-04 Chapter 24 Update for Security
Requirements
Inpatient Rehabilitation Facility (IRF) Annual Update: Prospective Payment
System (PPS) Pricer Changes for FY 2013 Payment Provisions Under IRF
PPS
New Fiscal Intermediary Shared System (FISS) Consistency Edit to Validate
Attending Physician NPI
Update-Inpatient Psychiatric Facilities Prospective Payment System (IPF
PPS) Fiscal Year (FY) 2013 Annual Update
Claim Adjustment Reason Code (CARC), Remittance Advice Remark Code
(RARC), and Medicare Remit Easy Print (MREP) and PC Print Update
Issued to a specific audience, not posted to Internetiintranet due to Sensitivity
of Instruction
Revised Medicare Summary Notice (MSN) Message Regarding Outpatient
Therapy Caps
Issued to a specific audience, not posted to Internetiintranetl due to
Confidentiality of Instruction
October 2012 Update of the Ambulatory Surgical Center Payment System
(ASC)
Annual Update for the Health Professional Shortage Area (HPSA) Bonus
Payments
Issued to a specific audience, not posted to Internetiintranetl due to Sensitivity
of Instruction
Instructions for Downloading the Medicare ZIP Code File for January 2013
Healthcare Common Procedure Coding System (HCPCS) Annual Update
Reminder
October Update to the CY 2012 Medicare Physician Fee Schedule Database
(MPFSDB)
October 2012 Update of the Hospital Outpatient Prospective Payment System
(OPPS)
Transitional Outpatient Payments (TOPs) for CY 2010 through CY 2012
Fiscal Intermediary Billing Requirements
Issued to a specific audience, not posted to Internetiintranet due to Sensitivity
of Instruction
Issued to a specific audience, not posted to Intemetiintranetl due to
Confidentiality of Instruction
Healthcare Provider Taxonomy Codes (HPTC) Update, October 2012
Chapter 24 Update to Remove Outdated Information FIs, Carriers, RHHIs,
AlB MACs, and CEDI HIPAA Claim Level Edits
Institutional Implementation Guide (IG) Edits Institutional Implementation
Guide and Direct Data Entry Edits
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
2496
2497
Based on Patient Assessments Systematic Validation of Claims Information
Using Patient Assessments
New Waived Tests
Update to Hospice Payment Rates, Hospice Cap, Hospice Wage Index and the
Hospice Prices for FY 2013
Issued to a specific audience, not posted to Internetiintranet due to Sensitivity
ofInstruction
Issued to a specific audience, not posted to InternetiIntraneti due to
Confidentiality of Instruction
Clarification of the Use of the Electronic Claim Format to Indicate Where a
Service Was Performed
Payment Jurisdiction Among Local BIMACs for Services Paid Under the
Physician Fee Schedule and Anesthesia Claims Processing Instructions for
Payment Jurisdiction
Conditional Data Element Requirements for AlB MACs and DMEMACs
Issued to a specific audience, not posted to Internetiintranetl due to
Confidentiality of Instruction
Issued to a specific audience, not posted to Internetiintranetl due to
Confidentiality of Instruction
Issued to a specific audience, not posted to InternetiIntraneti due to
Confidentiality of Instruction
Issued to a specific audience, not posted to Internetiintranet due to Sensitivity
ofInstruction
Issued to a specific audience, not posted to Internetiintranetl due to
Confidentiality of Instruction
Extracorporeal Photopheresis (ICD-l 0)
Medicare Part A Skilled Nursing Facility (SNF) Prospective Payment System
(PPS) Pricer Update FY 2013
Claim Status Category and Claim Status Codes Update
Issued to a specific audience, not posted to Internetiintranetl due to
Confidentiality of Instruction
Payment of Global Surgical Split Care in a Method II Critical Access Hospital
(CAH) Submitted with Modifier 54 and/or 55
Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Low Back
Pain (CLBP)
National Coverage Determination (NCD) for Transcatheter Aortic Valve
Replacement (TAVR)
Transcatheter Aortic Valve Replacement (TA VR) Furnished on or After
May 1,2012
Coding Requirements for Requirements for Transcatheter Aortic Valve
Replacement (TAVR) Services Furnished On or After May 1,2012
Claims Processing Requirements for TAVR Services on Professional Claims
Claims Processing Requirements for TAVR Services on Inpatient Hospital
Claim
Liver Transplantation for Patients with Malignancies Liver Transplants
October 2012 Quarterly Average Sales Price (ASP) Medicare Part B Drug
Pricing Files and Revisions to Prior Quarterly Pricing Files Notification for
Beneficiaries Exceeding Financial Limitations
Handling Form CMS-1500 Hard Copy Claims Where an ICD-9-CM "E"
67371
EN09NO12.010
tkelley on DSK3SPTVN1PROD with NOTICES
67372
VerDate Mar<15>2010
2538
2539
Jkt 229001
PO 00000
2540
Frm 00044
2541
2542
Fmt 4703
2543
Sfmt 4725
2544
E:\FR\FM\09NON1.SGM
2545
2546
2547
09NON1
87
88
89
211
212
EN09NO12.011
Indian Health Services (IHS) Hospital Payment Rates for Calendar Year 2012
Expiration of2012 Therapy Cap Revisions and User-Controlled Mechanism
to Identify Legislative Effective Dates S
Issued to a specific audience, not posted to Internet/Intranet due to Sensitivity
of Instruction
Fiscal Year (FY) 2013 Inpatient Prospective Payment System (IPPS), Long
Term Care Hospital (LTCH) PPS Changes Medicare Code Editor (MCE)
Disproportionate Share Hospital (DSH) Policy Changes Effective for Cost
Reporting Periods beginning on or after October 1, 2009
Disproportionate Share Hospital (DSH) Policy Changes Effective for Cost
Reporting Periods beginning on or after October 1, 2012
Repeat Admissions
Outpatient Services Treated as Inpatient Services
Replaced Devices Offered Without Cost or With a Credit
Addenda A-Provider Specific File
Issued to a specific audience, not posted to Internet/Intranet due to Sensitivity
ofInstruction
Issued to a specific, audience not posted to InternetlIntranet due to
Confidentiality of Instruction
2013 Annual Update of Healthcare Common Procedure Coding System
(HCPCS) Codes for Skilled Nursing Facility (SNF) Consolidated Billing
(CB) Update
Extracorporeal Photopheresis (ICD-l 0) Billing Requirements for
Extracorporeal Photopheresis
Healthcare Common Procedural Coding System (HCPCS), Applicable
Diagnosis Codes and Procedure Code Medicare Summary Notices (MSNs),
Remittance Advice Remark Codes (RAs) and Claim Adjustment Reason
Code
Contractor and Common Working File (CWF) Additional Instructions
Related to Change Request (CR) 7633 - Screening and Behavioral Counseling
Interventions in Primary Care to Reduce Alcohol Misuse
Issued to a specific audience, not posted to Internet/ Intranet due to
Confidentiality of Instruction
Instructions for Retrieving the 2013 Pricing and HCPCS Data Files through
CMS' Mainframe Telecommunications Systems
Claim Status Category and Claim Status Codes Update
Clarification of Medicare Conditional Payment Policy and Billing Procedures
for Liability, No-Fault and Workers' Compensation Medicare Secondary
Payer (MSP) Claims.
Expanding the Coordination of Benefits (COB) Contractor Numbers to
include 11139 and 11142 for the Common Working File (CWF) Definition of
MSP/CWF Terms
Expanding the Coordination of Benefits (COB) Contractor Numbers to
include 11139 and 11142 for the Common Working File (CWF)
Notice of New Interest Rate for Medicare Overpayments and Underpayments
- 4th Notification for FY 2011
New Non- Physician Specialty Code for Centralized Flu Claims Processing
210
Timeliness - All Claims
Part ElInterest Payment Data
Non-Physician Practitioner/Supplier Specialty Codes
Validation of Recovery Audit Program New Issues
82
CMS Certification Numbers for Medicaid-Only Hospitals and New State
Code for Foreign Countries
00
None
I
00
None
I
00
None
00
None
108
109
This is the initial release of New Chapter 21, Compliance Program Guidelines
This is the initial release of New Chapter 21, Compliance Program Guidelines
00
None
84
Revisions to the Method of Cost Settlement for Inpatient Services for Rural
Hospitals Participating Under Demonstration Authorized by Section 41 OA of
the Medicare Modernization Act. Sections 3123 and 10313 of the Affordable
Care Act authorizes an expansion of the demonstration and an extension for
an additional 5-year period. This CR makes revisions to CR 7505, which
gives instructions for the additional 5-year period.
1101
Reporting of Recoupment for Overpayment on the Remittance Advice (RA)
with Patient Control Number
Direction to Modify Institutional Reason Code 39012
Health Insurance Portability and Accountability Act (HIPAA) 5010 and D.O
Execution of the Annual Recertification Program
Issued to a specific audience, not posted to InternetlIntranet due to Sensitivity
of Instruction
Issued to a specific, audience not posted to Internet/Intranet due to
Confidentiality of Instruction
Posting the Limiting Charge after Applying the e-Prescribing (eRx) Negative
Adjustment
The Medicare Secondary Payer Payment Module (MSPPA Y) to be
Maintained by the Shared System Maintainers for all Future Enhancements
Fee For Service Common Eligibility Services (FFS CES) - Common Working
File (CWF) Detail Analysis, Design and Requirements
Issued to a specific, audience not posted to IntemetlIntranet due to
Confidentiality of Instruction
Revision of Medicare Summary Notice (MSN) for Non-Competitive Bid
Claims
Expand Place of Service Address to Include Full Address
I
I
1102
ll03
1104
ll05
1106
1107
1108
1109
1110
1111
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
2536
2537
tkelley on DSK3SPTVN1PROD with NOTICES
VerDate Mar<15>2010
1112
1114
1115
Jkt 229001
1116
1117
1118
PO 00000
1119
1120
Frm 00045
1121
1122
Fmt 4703
Sfmt 4725
E:\FR\FM\09NON1.SGM
09NON1
Addendum II: Regulation Documents Published
in the Federal Register (July through September 2012)
Regulations and Notices
Regulations and notices are published in the daily Federal
Register. To purchase individual copies or subscribe to the Federal
Register, contact GPO at www.gpo.gov!fdsys. When ordering individual
copies, it is necessary to cite either the date of publication or the volume
number and page number.
The Federal Register is available as an online database through
GPO Access. The online database is updated by 6 a.m. each day the
Federal Register is published. The database includes both text and
graphics from Volume 59, Number 1 (January 2, 1994) through the present
date and can be accessed at https://www.gpoaccess.gov/fr/. The
following Website https://www.archives.gov/federal-register/provides
information on how to access electronic editions, printed editions, and
reference copies.
This information is available on our Website at:
https://www .cms. gov!guarterlyproviderupdates!downloads/Regs3Q12QPU.pdf
For questions or additional information, contact Terri Plumb
(410-786-4481).
Addendum III: CMS Rulings
CMS Rulings are decisions of the Administrator that serve as
precedent final opinions and orders and statements of policy and
interpretation. They provide clarification and interpretation of complex or
ambiguous provisions of the law or regulations relating to Medicare,
Medicaid, Utilization and Quality Control Peer Review, private health
insurance, and related matters.
The rulings can be accessed at
https://www .cms. gov/Rulings!CMSRllist.asp#TopOfPage. For questions or
additional information, contact Tiffany Lafferty (410-786-7548).
Addendum IV: Medicare National Coverage Determinations
(July through September 2012)
Addendum IV includes completed national coverage
determinations (NCDs), or reconsiderations of completed NCDs, from the
quarter covered by this notice. Completed decisions are identified by the
section of the NCD Manual (NCDM) in which the decision appears, the
title, the date the publication was issued, and the effective date of the
decision. An NCD is a determination by the Secretary for whether or not a
particular item or service is covered nationally under the Medicare Program
(title XVIII ofthe Act), but does not include a determination of the code, if
any, that is assigned to a particular covered item or service, or payment
determination for a particular covered item or service. The entries below
include information concerning completed decisions, as well as sections on
program and decision memoranda, which also announce decisions or, in
some cases, explain why it was not appropriate to issue an NCD.
Information on completed decisions as well as pending decisions has also
been posted on the CMS website. For the purposes of this quarterly notice,
we list only the specific updates that have occurred in the 3-month period.
This information is available on our website at: www.cms.gov!medicarecoverage-database!. For questions or additional information, contact
Wanda BelleJ41O-786-7491).
Title
Liver Transplantation for
Malignancies
Transcutaneous Electrical Nerve
Stimulation (TENS) Chronic
Low Back Pain
I NCDM I Transmittal
Section
NCD
260.1
NCD
160.27
Number
I
Issue Date
I
Effective
Date
R146NCD
08/03/2012
07/1312012
R144NCD
08/03/2012
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
1113
Health Insurance Portability and Accountability Act (HIPAA) 5010 837
Institutional (8371) Edits and 5010 837 Professional (837P) Edits
January 2012
Issued to a specific audience, not posted to InternetlIntranet due to Sensitivity
of Instruction
New Field Established within FISS and MCS
Implement Fraud Prevention Predictive Modeling Prepayment Edits for
Shared Systems (xrefCR7787)
Implement Fraud Prevention Predictive Modeling Prepayment Edits for
Shared Systems (xrefCR7787)
Manual Medical Review of Therapy Services
Issued to a specific audience, not posted to InternetlIntranet due to Sensitivity
of Instruction
Implementation of the Award for the Jurisdiction 5 Part A and Part B
Medicare Administrative Contractor (J5 AlB MAC) Reprocurment Including
a New Workload Number for the Remaining WPS Legacy Workload
Issued to a specific, audience not posted to InternetlIntranet due to
Confidentiality of Instruction
None
International Classification of Diseases (ICD)-IO Conversion from ICD-9 and
Related Code Infrastructure of the Medicare Shared Systems as They Relate
to CMS National Coverage Determinations (NCDs) (CR 1 of3) (TCD-IO)
06/08/2012
67373
EN09NO12.012
tkelley on DSK3SPTVN1PROD with NOTICES
67374
VerDate Mar<15>2010
05/0112012
Jkt 229001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4725
IDE
E:\FR\FM\09NON1.SGM
09NON1
BB15140
GI00021
Gl101l2
GII0162
Gl10186
Gll0217
Gll0221
Gll0223
Gll0227
GII0229
G120008
G120010
G120021
Gl20030
G120075
G120076
Gl20077
G120092
G120104
G120133
EN09NO12.013
Device
Magellan System
Stentys Coronary Stent System
Formula Balloon-Expandable Stent
Solace Intra Vesical Bladder Control System
Spinal Modulation Neurostimulator System
Unify Quadra MP CRT-DS Device
Siello S Pacing Leads
Consulta CRT-P Device
Ingevity Active Fixation and Passive Fixation Pace
Surpass Intracranial Embolization System
Pulmonx Zephyr Endobronchial Valve
NEO Baroreflex Activation Therapy
Intuitive Surgical Davinci
Nucleus Cochlear Implant System
Vercise Deep Brain Stimulation
Samurai Clinical Study
Reliance 4-Front Clinical Study
Non-Invasive Reduction of Fat in the Inner Thighs with the Zeltiq
Cool Sculpting System
Robot-Assisted MRI-Guided Prostate Biopsy
Allegretto Wave Eye-Q Excimer Laser System
Start Date
07/06/12
09/12/12
07/18112
08/09/12
09/19/12
08/08/12
09/12/12
09/12/12
07/13/12
07/11112
07/19/12
08/24/12
08/07/12
07/19/12
07/25/12
08/16/12
07/10/12
07/12/12
08/09/12
07/03/12
Gl20151
Gl20152
Gl20155
Gl20162
Gl20164
Gl20166
Gl20169
Gl20171
Gl20175
Gl20176
Gl20181
Gl20183
Gl20188
Gl20191
Gl20194
Gl20195
Deviate-AF
Zenith P-Branch
Embosphere Microspheres
Solitaire FR Revascularization Device
Michi Neuroprotection System
Supera Veritas Peripheral Sten System
Subqstim Study
Rescue-VT
Tria Beauty Fan Precision Device
Implantable Myoelectric Sensors for Upper Extremity Prosthetic
Control in Transradial Amputees
Star S4 Excimer Laser System
Lifevest Wearable Cardioverter Defibrillator (WDC)
Prevent
Star SR IR Excimer Laser System and IDesign Advanced
Wavescan Studio for Wavefront-Guided Lasik Treatment of
Mixed Astig
Star SR IR Excimer Laser System and IDesign Advanced
Wavescan Studio for Wavefront-Guided Lasik Treatment of
Hyperopia
U1thera System Model 8850-0001
Surtavi
Medtronic Reveal XT Isertable Cardiac Monitor Model 9529
Native Outflow Tract TPV System
B-Tevar Device
Intra-Articular Hyaluronan
C-Met Immunohistochemistry
Pulmonary Artery Repair with Covered Cheatham Platinum Stent
The Lone AFIB Trial
Nucleus 24 Auditory Brainstem Implant
The Moe Plasma Treatment System
07/06/12
07/11112
09/11112
07/18/12
07/18/12
07/18/12
07120/12
07/19112
07/18/12
07125/12
07/24/12
07/25/12
07126/12
08/08/12
08/08112
08/15/12
08/15112
08124/12
08/30/12
08124112
08129/12
09/05/12
09/12/12
09/19112
09121112
09/17/12
Addendum VI: Approval Numbers for Collections of Information
(July through September 2012)
All approval numbers are available to the public at Reginfo.gov.
Under the review process, approved information collection requests are
assigned OMB control numbers. A single control number may apply to
several related information collections. This information is available at
www.reginfo.gov/publicldo/PRAMain. For questions or additional
information, contact Mitch Bryman (410-786-5258).
Addendum VII: Medicare-Approved Carotid Stent Facilities,
(July through September 2012)
Addendum VII includes listings of Medicare-approved carotid
stent facilities. All facilities listed meet CMS standards for performing
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
Addendum V: FDA-Approved Category B Investigational Device
Exemptions (IDEs) (July through September 2012)
Addendum V includes listings of the FDA-approved
investigational device exemption (IDE) numbers that the FDA assigns. The
listings are organized according to the categories to which the devices are
assigned (that is, Category A or Category B), and identified by the IDE
number. For the purposes of this quarterly notice, we list only the specific
updates to the Category B IDEs as of the ending date of the period covered
by this notice and a contact person for questions or additional information.
For questions or additional information, contact John Manlove (410-7866877).
Under the Food, Drug, and Cosmetic Act (21 U.S.C. 360c) devices
fall into one ofthree classes. To assist CMS under this categorization
process, the FDA assigns one of two categories to each FDA-approved
investigational device exemption (IDE). Category A refers to experimental
IDEs, and Category B refers to non-experimental IDEs. To obtain more
information about the classes or categories, please refer to the notice
published in the April 21, 1997 Federal Register (62 FR 19328).
Gl20135
Gl20136
Gl20141
Gl20142
Gl20143
Gl20144
Gl20146
Gl20147
Gl20149
Gl20150
tkelley on DSK3SPTVN1PROD with NOTICES
VerDate Mar<15>2010
Jkt 229001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4725
E:\FR\FM\09NON1.SGM
09NON1
Facility
Provider
Number
Effective
Date
State
Carlsbad Medical Center
2430 W. Pierce Street Carlsbad, NM 88220
Denver Health Medical Center
777 Bannock Street, MC0960 Denver, CO 80204
Galion Community Hospital
269 Portland Way South Galion, OH 44833
Beaumont Health System - Troy
44201 Dequindre Road Troy, MI 48085
Texoma Medical Center
5016 South US Hwy 75 Denison, TX 75020
McLaren-Lapeer Region
1375 North Main Street Lapeer, MI 48446-1350
Lutheran Medical Center
150 55th Street Brooklyn, NY 11220-2574
Southside Regional Medical Center
200 Medical Park Boulevard Petersburg, VA 23805
Saint Agnes Hospital
900 Caton Avenue Baltimore, MD 21229
Mercy Hospital Washington
901 E 5th Street Washington, MO 63090
St. Joseph Regional Medical Center
415 6th Street Lewiston, ill 83501
320065
07/1112012
NM
060011
07/1112012
CO
1215907522
07/18/2012
OH
1306825997
07/25/2012
MI
1851390967
07/25/2012
TX
230193
08/06/2012
MI
330306
08/20/2012
NY
490067
08/29/2012
VA
210011
09/10/2012
MD
260052
09113/2012
MO
1225090954
09/24/2012
ill
350070
06105/2007
ND
From: Dakota Specialty Institute
To: Innovis Health dba Essentia Health
3000 32nd Avenue SW Fargo, ND 58104
Facility
I Provider
I Effective
State
Date
07/06/2006
IN
330005
05/03/2005
NY
170123
05/16/2005
KS
280030
06/27/2005
NE
Addendum Vill:
American College of Cardiology's National Cardiovascular Data
Registry Sites (July through September 2012)
Addendum VIII includes a list of the American College of
Cardiology's National Cardiovascular Data Registry Sites. We cover
implantable cardioverter defibrillators (ICDs) for certain clinical
indications, as long as information about the procedures is reported to a
central registry. Detailed descriptions ofthe covered indications are
available in the NCD. In January 2005, CMS established the ICD
Abstraction Tool through the Quality Network Exchange (QNet) as a
temporary data collection mechanism. On October 27,2005, CMS
announced that the American College of Cardiology's National
Cardiovascular Data Registry (ACC-NCDR) ICD Registry satisfies the data
reporting requirements in the NCD. Hospitals needed to transition to the
ACC-NCDR ICD Registry by April 2006.
Effective January 27,2005, to obtain reimbursement, Medicare
NCD policy requires that providers implanting ICDs for primary prevention
clinical indications (that is, patients without a history of cardiac arrest or
spontaneous arrhythmia) report data on each primary prevention ICD
procedure. Details of the clinical indications that are covered by Medicare
and their respective data reporting requirements are available in the
Medicare NCD Manual, which is on the CMS Website at
htlp:llwww.cms.hhs.govlManuals/IOMIitemdetail.asp?filterType=none&filt
erByDID=99&sortByDID= 1&sortOrder=ascending&itemID=CMSO 14961
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
carotid artery stenting for high risk patients. On March 17,2005, we issued
our decision memorandum on carotid artery stenting. We determined that
carotid artery stenting with embolic protection is reasonable and necessary
only if performed in facilities that have been determined to be competent in
performing the evaluation, procedure, and follow-up necessary to ensure
optimal patient outcomes. We have created a list of minimum standards for
facilities modeled in part on professional society statements on competency.
All facilities must at least meet our standards in order to receive coverage
for carotid artery stenting for high risk patients. For the purposes of this
quarterly notice, we are providing only the specific updates that have
occurred in the 3-month period. This information is available on our
website at:
https://www .cms. govlMedicareApprovedF acilitie/CASFIlist.asp#TopOfPage
For questions or additional information, contact Sarah J. McClain
(410-786-2294).
67375
EN09NO12.014
tkelley on DSK3SPTVN1PROD with NOTICES
67376
VerDate Mar<15>2010
Jkt 229001
Addendum IX: Active CMS Coverage-Related Guidance Documents
(July through September 2012)
There were no CMS coverage-related guidance documents
published in the July through September 2012 quarter. To obtain full-text
copies of these documents, visit the CMS Coverage website at
https://www.cms.gov/mcd/index list.asp?list type=mcd 1 and click on the
archives link. For questions or additional information, contact Lori Ashby
(410-786-6322).
PO 00000
Frm 00048
Fmt 4703
Sfmt 4725
E:\FR\FM\09NON1.SGM
09NON1
Facility Name
City
State
Addendum X:
List of Special One-Time Notices Regarding National Coverage
Provisions (July through September 2012)
There were no special one-time notices regarding national
coverage provisions published in the July through September 2012 quarter.
This information is available at www.cms.hhs.gov/coverage. For questions
or additional information, contact Lori Ashby (410-786-6322).
Children's Mercy Hospital
Norwegian American Hospital
Lake Wales Medical Center
Thomas Hospital
Ephraim McDowell Regional Medical Center
Ponca City Medical Center
Northwestern Lake Forest Hospital
Wentworth-Douglass Hospital
Oro Valley Hospital
Seton Medical Center Harker Heights
Jupiter Medical Center
Hendricks Regional Health
St. Anthony's Hospital
Maine General Medical Center
Southeast Georgia Health System
Central Vermont Medical Center Inc
Opelousas General Health System
Lodi Memorial Hospital
Memorial Hospital of Tampa
San Francisco Heart and Vascular Institute
Feather River Hospital
Mercy Memorial Hospital
Palestine Regional Medical Center
University Medical Center
Kansas City
Chicago
Lake Wales
Fairhope
Danville
Ponca City
Lake Forest
Dover
Ora Valley
Harker Heights
Jupiter
Danville
Houston
Augusta
Brunswick
Berlin
Opelousas
Lodi
Tampa
Daly City
Paradise
Monroe
Palestine
Lubbock
MO
IL
FL
AL
KY
OK
IL
NH
AZ
TX
FL
IN
TX
ME
GA
VT
LA
CA
FL
CA
CA
MI
TX
TX
Addendum XI: National Oncologic PET Registry (NOPR)
(July through September 2012)
Addendum XI includes a listing of National Oncologic Positron
Emission Tomography Registry (NOPR) sites. We cover positron emission
tomography (PET) scans for particular oncologic indications when they are
performed in a facility that participates in the NOPR.
In January 2005, we issued our decision memorandum on positron
emission tomography (PET) scans, which stated that CMS would cover
PET scans for particular oncologic indications, as long as they were
performed in the context of a clinical study. We have since recognized the
National Oncologic PET Registry as one of these clinical studies.
Therefore, in order for a beneficiary to receive a Medicare-covered PET
scan, the beneficiary must receive the scan in a facility that participates in
the registry. There were no updates to the listing of National Oncologic
Positron Emission Tomography Registry (NOPR) in the July through
September 2012 quarter. This information is available at
https://www.cms.govlMedicareApprovedFacilitieINOPRIlist.asp#TopOtPag
s;.
For questions or additional information, contact Stuart Caplan, RN, MAS
(410-786-8564)
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
EN09NO12.015
A provider can use either of two mechanisms to satisfy the data
reporting requirement. Patients may be enrolled either in an Investigational
Device Exemption trial studying ICDs as identified by the FDA or in the
ACC-NCDR ICD registry. Therefore, for a beneficiary to receive a
Medicare-covered ICD implantation for primary prevention, the beneficiary
must receive the scan in a facility that participates in the ACC-NCDR ICD
registry. The entire list of facilities that participate in the ACC-NCDR ICD
registry can be found at www.ncdr.comlwebncdr/common
For the purposes of this quarterly notice, we are providing only the
specific updates that have occurred in the 3-month period. This information
is available by accessing our website and clicking on the link for the
American College of Cardiology's National Cardiovascular Data Registry
at: www.ncdr.comlwebncdr/common. For questions or additional
information, contact Joanna Baldwin, MS (410-786-7205).
tkelley on DSK3SPTVN1PROD with NOTICES
VerDate Mar<15>2010
Jkt 229001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4725
E:\FR\FM\09NON1.SGM
09NON1
Facility
Provider Number
Date Approved
State
Abington Memorial Hospital
1200 Old York Road
Abington, PA 19001
Froedtert Memorial Lutheran Hospital
9200 West Wisconsin Avenue
Milwaukee, WI 53226
Maimonides Medical Center
4802 Tenth Avenue
Brooklyn, NY 11219
390231
07/10/2012
PA
520177
08/0112012
Wi
330194
08/24/2012
NY
Addendum XIII: Lung Volume Reduction Surgery (L VRS)
(July through September 2012)
Addendum XIII includes a listing of Medicare-approved facilities
that are eligible to receive coverage for lung volume reduction surgery.
Until May 17,2007, facilities that participated in the National Emphysema
Treatment Trial were also eligible to receive coverage. The following three
types of facilities are eligible for reimbursement for Lung Volume
Reduction Surgery (LVRS):
• National Emphysema Treatment Trial (NETT) approved (Beginning
05/07/2007, these will no longer automatically qualify and can qualify only
with the other programs);
• Credentialed by the Joint Commission (formerly, the Joint
Commision on Accreditation of Healthcare Organizations (JCAHO)) under
their Disease Specific Certification Program for LVRS; and
• Medicare approved for lung transplants.
Only the first two types are in the list. There were no additions to
the listing of facilities for lung volume reduction surgery published in the
July through September 2012 quarter. This information is available on our
website at
www.cms.govlMedicareApprovedF acilitielLVRS/list.asp#TopOtPage. For
questions or additional information, contact JoAnna Baldwin, MS
(410-786-7205).
Addendum XIV: Medicare-Approved Bariatric Surgery Facilities
(July through September 2012)
Addendum XIV includes a listing of Medicare-approved facilities
that meet minimum standards for facilities modeled in part on professional
society statements on competency. All facilities must meet our standards in
order to receive coverage for bariatric surgery procedures. On February 21,
2006, we issued our decision memorandum on bariatric surgery procedures.
We determined that bariatric surgical procedures are reasonable and
necessary for Medicare beneficiaries who have a body-mass index (BMI)
greater than or equal to 35, have at least one co-morbidity related to obesity
and have been previously unsuccessful with medical treatment for obesity.
This decision also stipulated that covered bariatric surgery procedures are
reasonable and necessary only when performed at facilities that are: (1)
certified by the American College of Surgeons (ACS) as a Levell Bariatric
Surgery Center (program standards and requirements in effect on February
15,2006); or (2) certified by the American Society for Bariatric Surgery
(ASBS) as a Bariatric Surgery Center of Excellence (BSCOE) (program
standards and requirements in effect on February 15,2006).
For the purposes of this quarterly notice, we list only the specific
updates to Medicare-approved facilities that meet CMS's minimum facility
standards for bariatric surgery and have been certified by ACS and/or
ASMBS in the 3-month period. This information is available on our
website at
www.cms.govlMedicareApprovedFacilitielB SFIlist.asp#TopOtPage. For
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
Addendum XII: Medicare-Approved Ventricular Assist Device
(Destination Therapy) Facilities (July through September 2012)
Addendum XII includes a listing of Medicare-approved facilities
that receive coverage for ventricular assist devices (VADs) used as
destination therapy. All facilities were required to meet our standards in
order to receive coverage for V ADs implanted as destination therapy. On
October 1, 2003, we issued our decision memorandum on V ADs for the
clinical indication of destination therapy. We determined that V ADs used
as destination therapy are reasonable and necessary only if performed in
facilities that have been determined to have the experience and
infrastructure to ensure optimal patient outcomes. We established facility
standards and an application process. All facilities were required to meet
our standards in order to receive coverage for VADs implanted as
destination therapy.
For the purposes of this quarterly notice, we are providing only the
specific updates that have occurred to the list of Medicare-approved
facilities that meet our standards in the 3-month period. This information is
available on our website at
htip:llwww.cms.gov/MedicareApprovedFacilitieNAD/list.asp#TopOtPage.
For questions or additional information, contact JoAnna Baldwin, MS
(410-786-7205).
67377
EN09NO12.016
tkelley on DSK3SPTVN1PROD with NOTICES
67378
VerDate Mar<15>2010
Jkt 229001
PO 00000
Frm 00050
Fmt 4703
Sfmt 9990
E:\FR\FM\09NON1.SGM
09NON1
Facility
Provider
Number
Date
Approved
State
Greater Baltimore Medical Center (GBMC)
Comprehensive Obesity Management Program
6535 North Charles Street Physicians Pavilion North,
Suite 125 Baltimore, MD 21204
The Bryn Mawr Hospital
130 South Bryan Mawr Avenue Bryn Mawr, PA
19010
Hurley Medical Center
One Hurley Plaza Flint, MI 48503-5993
Surgical Weight Loss Program at Eastern Maine
Medical Center
905 Union Street, Suite II Bangor, ME 4401
Saint Vincent Hospital
123 Summer Street Worcester, MA 01608
Mount Sinai Hospital
5 East 98th Street, 15th Floor New York, NY 10029
1396774238
06/07/12
MD
24371
03/16112
PA
230132
04/14/12
MI
1790789147
06/10/12
ME
220176
06/10/10
MA
1932103413
07/15/11
NY
1386749893
05/30/2007
IN
220175
07/14/2010
MA
260104
02/24/2006
MO
140213
03/1012006
IL
MPI1790717650;
PI-220 11 0
330013
08/14/2012
MA
06/02/2012
NY
010078
07/30/2007
AL
01-0054
12/18/2009
AL
390050
1112112006
PA
St. Francis Hospital & Health Centers
1600 Albany Street Beech Grove, IN 46107
MetroWest Medical Center, Leonard Morse Hospital
67 Union Street, Fair 4 Natick, MAOl760
SSM DePaul Health Center
12266 DePaul Drive, Suite 310 Bridgeton, MO 63044
Silver Cross Hospital and Medical Centers
1900 Silver Cross Boulevard
New Lenox, IL. 60451-9508
Brigham and Women's Hospital
75 Francis Street ASBII-3
Boston, MA 02115-619
Albany Medical Center
47 New Scotland Avenue Albany, NY 12208
Northeast Alabama Regional Medical Center
400 East 10th Street Anniston, AL 36207
Parkway Medical Center
1854 Beltline Road SW Decatur, AL 35601
Allegheny General Hospital
320 East North Avenue Pittsburgh, PA 15212
EN09NO12.017
Addendum XV: FDG-PET for Dementia and Neurodegenerative
Diseases Clinical Trials (July through September 2012)
There were no FDG-PET for Dementia and Neurodegenerative
Diseases Clinical Trials published in the July through September 2012
quarter.
This information is available on our website at
www.cms.govlMedicareApprovedFacilitieIPETDT/list.asp#TopOfPage.
For questions or additional information, contact Stuart Caplan, RN, MAS
(410-786-8564).
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
17:34 Nov 08, 2012
questions or additional information, contact Kate Tillman, RN, MAS
(410-786-9252).
Federal Register / Vol. 77, No. 218 / Friday, November 9, 2012 / Notices
[FR Doc. 2012–27422 Filed 11–08–12; 8:45 am]
BILLING CODE 4120–01–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–D–1057]
Draft Guidance for Industry and Food
and Drug Administration Staff; Highly
Multiplexed Microbiological/Medical
Countermeasure In Vitro Nucleic Acid
Based Diagnostic Devices; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of the draft guidance
entitled ‘‘Highly Multiplexed
Microbiological/Medical
Countermeasure In Vitro Nucleic Acid
Based Diagnostic Devices.’’ This draft
guidance is to provide industry and
Agency staff with recommendations for
studies to establish the analytical and
clinical performance of highly
multiplexed microbiological/medical
countermeasures in vitro nucleic acid
based diagnostic devices (HMMDs)
intended to simultaneously detect and
identify multiple pathogen nucleic acids
extracted from a single appropriate
human specimen or culture. This draft
guidance is not final nor is it in effect
at this time.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by February 7,
2013.
ADDRESSES: Submit written requests for
single copies of the draft guidance
document entitled ‘‘Highly Multiplexed
Microbiological/Medical
Countermeasure In Vitro Nucleic Acid
Based Diagnostic Devices’’ to the
Division of Small Manufacturers,
International, and Consumer Assistance,
Center for Devices and Radiological
Health, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 66,
rm. 4613, Silver Spring, MD 20993–
0002. Send one self-addressed adhesive
label to assist that office in processing
your request, or fax your request to 301–
847–8149. See the SUPPLEMENTARY
INFORMATION section for information on
electronic access to the guidance.
Submit electronic comments on the
draft guidance to https://
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:34 Nov 08, 2012
Jkt 229001
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Identify
comments with the docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: John
Hobson, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, rm. 5555, Silver Spring,
MD 20993–0002, 301–796–5892.
SUPPLEMENTARY INFORMATION:
I. Background
This draft guidance is to provide
industry and Agency staff with
recommendations for studies to
establish the analytical and clinical
performance of HMMDs intended to
simultaneously detect and identify
multiple pathogen nucleic acids
extracted from a single appropriate
human specimen or culture. For the
purposes of this draft guidance
document the multiplex level that is
used to define HMMDs is the capability
to detect ≥20 different organisms/
targets, in a single reaction, using a
nucleic acid based technology and
involves testing multiple targets through
a common process of specimen
preparation, amplification and/or
detection, and result interpretation.
HMMDs are used to aid in the diagnosis
of infection.
The scope of this draft guidance
includes nucleic acid based devices that
employ technologies such as
polymerase chain reaction, reversetranscriptase polymerase chain reaction,
bead-based liquid arrays, microarrays,
re-sequencing approaches as well as the
measurement of individual targets
determined by ≥20 separate assays that
are reported out simultaneously through
the use of a diagnostic algorithm. This
draft guidance is not intended to
address devices that utilize detection
mechanisms other than nucleic acid
based approaches. The document does
not apply to devices that are intended
to screen donors of blood and blood
components, and donors of human cells,
tissues, and cellular and tissue-based
products for communicable diseases.
II. Significance of Guidance
This draft guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the Agency’s current thinking
on highly multiplexed microbiological/
medical countermeasure in vitro nucleic
acid based diagnostic devices. It does
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
67379
not create or confer any rights for or on
any person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable statute and regulations.
III. Electronic Access
Persons interested in obtaining a copy
of the draft guidance may do so by using
the Internet. A search capability for all
CDRH guidance documents is available
at https://www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/
GuidanceDocuments/default.htm.
Guidance documents are also available
at https://www.regulations.gov. To
receive ‘‘Highly Multiplexed
Microbiological/Medical
Countermeasure In Vitro Nucleic Acid
Based Diagnostic Devices,’’ you may
either send an email request to
dsmica@fda.hhs.gov to receive an
electronic copy of the document or send
a fax request to 301–847–8149 to receive
a hard copy. Please use the document
number 1803 to identify the guidance
you are requesting.
IV. Paperwork Reduction Act of 1995
This draft guidance refers to currently
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
21 CFR parts 801 and 809 have been
approved under OMB control number
0910–0485; the collections of
information in 21 CFR part 807, subpart
E, have been approved under OMB
control number 0910–0120; and the
collections of information in 21 CFR
part 820 have been approved under
OMB control number 0910–0073.
V. Comments
Interested persons may submit either
written comments regarding this
document to the Division of Dockets
Management (see ADDRESSES) or
electronic comments to https://
www.regulations.gov. It is only
necessary to send one set of comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
E:\FR\FM\09NON1.SGM
09NON1
Agencies
[Federal Register Volume 77, Number 218 (Friday, November 9, 2012)]
[Notices]
[Pages 67368-67379]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-27422]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-9075-N]
Medicare and Medicaid Programs; Quarterly Listing of Program
Issuances--July through September 2012
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This quarterly notice lists CMS manual instructions,
substantive and interpretive regulations, and other Federal Register
notices that were published from July through September 2012, relating
to the Medicare and Medicaid programs and other programs administered
by CMS.
FOR FURTHER INFORMATION CONTACT: It is possible that an interested
party may need specific information and not be able to determine from
the listed information whether the issuance or regulation would fulfill
that need. Consequently, we are providing contact persons to answer
general questions concerning each of the addenda published in this
notice.
------------------------------------------------------------------------
Addenda Contact Phone No.
------------------------------------------------------------------------
I CMS Manual Instructions........ Ismael Torres...... (410) 786-1864
II Regulation Documents Published Terri Plumb........ (410) 786-4481
in the Federal Register.
III CMS Rulings.................. Tiffany Lafferty... (410) 786-7548
IV Medicare National Coverage Wanda Belle........ (410) 786-7491
Determinations.
V FDA-Approved Category B IDEs... John Manlove....... (410) 786-6877
VI Collections of Information.... Mitch Bryman....... (410) 786-5258
VII Medicare-Approved Carotid Sarah J. McClain... (410) 786-2294
Stent Facilities.
VIII American College of JoAnna Baldwin, MS. (410) 786-7205
Cardiology-National
Cardiovascular Data Registry
Sites.
IX Medicare's Active Coverage- Lori Ashby......... (410) 786-6322
Related Guidance Documents.
X One-Time Notices Regarding Lori Ashby......... (410) 786-6322
National Coverage Provisions.
XI National Oncologic Positron Stuart Caplan, RN, (410) 786-8564
Emission Tomography Registry MAS.
Sites.
XII Medicare-Approved Ventricular JoAnna Baldwin, MS. (410) 786-7205
Assist Device (Destination
Therapy) Facilities.
XIII Medicare-Approved Lung JoAnna Baldwin, MS. (410) 786-7205
Volume Reduction Surgery
Facilities.
XIV Medicare-Approved Bariatric Kate Tillman, RN, (410) 786-9252
Surgery Facilities. MAS.
XV Fluorodeoxyglucose Positron Stuart Caplan, RN, (410) 786-8564
Emission Tomography for Dementia MAS.
Trials.
All Other Information............ Annette Brewer..... (410) 786-6580
------------------------------------------------------------------------
I. Background
Among other things, the Centers for Medicare & Medicaid Services
(CMS) is responsible for administering the Medicare and Medicaid
programs and coordination and oversight of private health insurance.
Administration and oversight of these programs involves the following:
(1) Furnishing information to Medicare and Medicaid beneficiaries,
health care providers, and the public; and (2) maintaining effective
communications with CMS regional offices, State governments, State
Medicaid agencies, State survey agencies, various providers of health
care, all Medicare contractors that process claims and pay bills,
National Association of Insurance Commissioners (NAIC), health
insurers, and other stakeholders. To implement the various statutes on
which the programs are based, we issue regulations under the authority
granted to the Secretary of the Department of Health and Human Services
under sections 1102, 1871, 1902, and related provisions of the Social
Security Act (the Act) and Public Health Service Act. We also issue
various manuals, memoranda, and statements necessary to administer and
oversee the programs efficiently.
Section 1871(c) of the Act requires that we publish a list of all
Medicare manual instructions, interpretive rules, statements of policy,
and guidelines of general applicability not issued as regulations at
least every 3 months in the Federal Register.
II. Revised Format for the Quarterly Issuance Notices
While we are publishing the quarterly notice required by section
1871(c) of the Act, we will no longer republish duplicative information
that is available to the public elsewhere. We believe this approach is
in alignment with CMS' commitment to the general principles of the
President's Executive Order 13563 released January 2011entitled
``Improving Regulation and Regulatory Review,'' which promotes
modifying and streamlining an agency's regulatory program to be more
effective in achieving regulatory objectives. Section 6 of Executive
Order 13563 requires agencies to identify regulations that may be
``outmoded, ineffective, insufficient, or excessively burdensome, and
to modify, streamline, expand or repeal them in accordance with what
has been learned.'' This approach is also in alignment with the
President's Open Government and Transparency Initiative that
establishes a system of transparency, public participation, and
collaboration.
Therefore, this quarterly notice provides only the specific updates
that have occurred in the 3-month period along with a hyperlink to the
full listing that is available on the CMS Web site or the appropriate
data registries that are used as our resources. This information is the
most current up-to-date information and will be available earlier than
we publish our quarterly notice. We believe the Web site list provides
more timely access for beneficiaries, providers, and suppliers. We also
believe the Web site offers a more convenient tool for the public to
find the full list of qualified providers for these specific services
and offers more flexibility and ``real time'' accessibility. In
addition, many of the Web sites have listservs; that is, the public can
subscribe and receive immediate notification of any updates to the Web
site. These listservs avoid the need to check the Web site, as
notification of
[[Page 67369]]
updates is automatic and sent to the subscriber as they occur. If
assessing a Web site proves to be difficult, the contact person listed
can provide information.
III. How To Use the Notice
This notice is organized into 15 addenda so that a reader may
access the subjects published during the quarter covered by the notice
to determine whether any are of particular interest. We expect this
notice to be used in concert with previously published notices. Those
unfamiliar with a description of our Medicare manuals should view the
manuals at https://www.cms.gov/manuals.
Authority: (Catalog of Federal Domestic Assistance Program No.
93.773, Medicare--Hospital Insurance, Program No. 93.774, Medicare--
Supplementary Medical Insurance Program, and Program No. 93.714,
Medical Assistance Program)
Dated: November 5, 2012.
Kathleen Cantwell,
Director, Office of Strategic Operations and Regulatory Affairs.
BILLING CODE 4120-01-P
[[Page 67370]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.009
[[Page 67371]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.010
[[Page 67372]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.011
[[Page 67373]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.012
[[Page 67374]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.013
[[Page 67375]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.014
[[Page 67376]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.015
[[Page 67377]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.016
[[Page 67378]]
[GRAPHIC] [TIFF OMITTED] TN09NO12.017
[[Page 67379]]
[FR Doc. 2012-27422 Filed 11-08-12; 8:45 am]
BILLING CODE 4120-01-C